Abstract
Adiponectin (APN), also known as apM1, Acrp30, GBP28 and adipoQ, is a circulating hormone that is predominantly produced by adipose tissue. Many pharmacological studies have demonstrated that this protein possesses potent anti-diabetic, anti-atherogenic and anti-inflammatory properties. Although several studies have demonstrated the antioxidative activity of this protein, the regulatory mechanisms have not yet been defined in skeletal muscles. The aim of the present study was to examine the cytoprotective effects of APN against damage induced by oxidative stress in mouse-derived C2C12 myoblasts. APN attenuated H2O2-induced growth inhibition and exhibited scavenging activity against intracellular reactive oxygen species that were induced by H2O2. Furthermore, treating C2C12 cells with APN significantly induced heme oxygenase-1 (HO-1) and nuclear factor-erythroid 2 related factor 2 (Nrf2). APN also suppressed H2O2-induced mitophagy and partially inhibited the colocalization of mitochondria with autophagosomes/lysosomes, correlating with the expression of Pink1 and Parkin and mtDNA. Moreover, APN protected C2C12 myoblasts against oxidative stress-induced apoptosis. Furthermore, APN significantly reduced the mRNA and protein expression levels of Bax. These data suggest that APN has a moderate regulatory role in oxidative stress-induced mitophagy and suppresses apoptosis. These findings demonstrate the antioxidant potential of APN in oxidative stress-associated skeletal muscle diseases.
Introduction
Oxidative stress, which is the pathological basis of many chronic diseases, results from disturbance of the balance between free radicals and antioxidant defenses1. Free radicals are generated in the form of reactive oxygen species (ROS), including short-lived superoxide anions, more stable hydrogen peroxide molecules and highly reactive hydroxyl radicals2, 3. ROS can be generated during mitochondrial oxidative phosphorylation or by several enzymes, including NADPH oxidases, xanthine oxidases and lipoxygenases. At low levels, ROS act as second messengers of signal transduction and participate in cellular signaling processes. Conversely, excessive ROS can lead to destructive and irreversible damage to all cellular constituents, such as nucleic acids, proteins and lipids4; therefore, ROS levels must be tightly regulated5.
Mitochondria have major roles in many cellular processes, including ATP production, fatty acid oxidation, cell survival, apoptosis, and necrosis6, 7. The accumulation of ROS within mitochondria can cause mitochondrial DNA mutations, lipid peroxidation and the opening of mitochondrial membrane channels including inner membrane anion channels (IMACs) and mitochondrial permeability transition pores (MPTPs). The opening of these channels leads to a transient increase in ROS generation referred to as ROS-induced ROS release (RIRR) and a decrease in mitochondrial membrane potential4. Furthermore, the opening of the MPTPs increases the permeability of mitochondria, which might cause a decrease in ATP concentrations and mitochondrial swelling8–10. The elimination of damaged mitochondria is essential for ensuring efficient energy supply and maintaining mitochondrial quality. There are two major catabolic processes by which dysfunctional mitochondria are degraded: one is the ubiquitin-proteasome system for eliminating mitochondrial outer membrane proteins, and the other is the autophagy-lysosome pathway for degrading mitochondria as whole organelles11, 12. The latter process, also known as mitophagy, selectively excludes damaged mitochondria via a specific autophagic pathway13.
Autophagy involves catabolism of cellular constituents, including organelles, the cytosol and proteins; this process occurs through the encapsulation of cellular components into a double-membrane structure termed an autophagosome14, 15. Two types of macroautophagy have been identified. In nutrient-deficient circumstances, non-selective autophagy supplies cells with essential metabolites and energy until nutrients can be obtained from the environment16. By contrast, under nutrient-rich conditions, selective autophagy mediates the removal of damaged or excess organelles, such as peroxisomes17, endoplasmic reticulum (ER)18–21 and mitochondria22, and accumulating evidence suggests that preferential autophagic processes are induced in response to ROS4. Mitophagy has been proposed to decrease potential oxidative damage due to dysfunctional mitochondria. However, recent reports have shown that a form of autophagic cell death is activated in response to oxidative stress23.
Adiponectin (APN), also known as 30-kDa adipocyte complement-related protein, is a hormone that is abundantly secreted by adipocytes24. Several experimental studies have suggested that APN exhibits insulin-sensitizing25, anti-atherogenic26 and anti-inflammatory properties27, 28 and can exert a modulatory effect on oxidative stress29, 30. In addition, it has been shown that APN attenuates oxidative stress-induced autophagy in cardiomyocytes30. While imbalance between ROS production and elimination results in oxidative stress, which has been implicated in numerous skeletal muscle diseases, including age-related loss of muscle quantity(sarcopenia31, 32), age-related loss of muscle strength (dynapenia33), early-onset myopathies34 and many muscular dystrophies35, 36, the mechanisms underlying the impairment have not been elucidated. In the present study, a specific ROS, H2O2, was both sufficient and essential for inducing oxidative stress4. Although pathophysiological levels of H2O2 increase oxidative stress and apoptosis in mouse-derived C2C12 myoblasts3, little is known regarding the effects of APN on the pathophysiological processes of ROS-induced autophagy. Therefore, we sought to validate the hypothesis that APN modulates the pathophysiological levels of ROS-induced autophagy in C2C12 myoblasts and to elucidate the underlying mechanism. Our results indicate that APN protects skeletal muscles from oxidative stress-induced damage.
Results
APN reduces H2O2-induced C2C12 cytotoxicity
Cells were first treated with a wide range of APN concentrations (1 to 30 μg/mL) for 24 h to determine the effect of APN on the viability of C2C12 cells. APN treatment at concentrations up to 30 μg/mL did not result in any cytotoxic effects, whereas cell viability increased at the concentration of 30 μg/mL (Fig. 1A). Cell viability dose-dependently decreased at concentrations from 1 to 5 mM H2O2 (Fig. 1B) and time-dependently decreased from 1 to 3 h (Fig. 1C). Therefore, 30 μg/mL APN was chosen as the optimal dose for studying the cytoprotective effect of APN against H2O2-induced cell damage. To examine the protective effect of APN on H2O2-induced cytotoxicity, C2C12 cells were treated with 30 μg/mL APN 24 h prior to H2O2 treatment, and then cell viability was measured. Our results indicated that treatment with 5 mM H2O2 alone reduced cell viability by approximately 50% after 1 h. Cytotoxicity was induced by 5 mM H2O2 for 1 h; other study reports 1 mM H2O2 for 6 h3. However, pretreatment with APN significantly protected cells against the H2O2-induced reduction in cell viability (Fig. 1D), indicating that the exposure of C2C12 cells to APN conferred a protective effect against oxidative stress.
APN attenuates H2O2-induced ROS generation and apoptosis in C2C12 cells
We next investigated whether APN affected intracellular ROS generation due to H2O2 treatment using a 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) assay. As previously reported, ROS levels increased in H2O2-treated cells compared with untreated cells37. However, ROS levels were significantly inhibited in the presence of APN (Fig. 2A,B). To further evaluate the cytoprotective effects of APN that resulted from the prevention of H2O2-induced apoptosis, the frequency of apoptotic cells was detected by flow cytometry. The results showed that the treatment of C2C12 cells with APN prior to H2O2 exposure strongly protected the cells against apoptosis (Fig. 2C,D). These results indicate that oxidative stress-induced apoptosis is mediated by ROS generation and that APN exerts a potent ROS scavenging effect, preventing H2O2-induced apoptosis. As nuclear factor-erythroid 2 related factor 2 (Nrf2) is a master antioxidant transcription regulator38, 39, we evaluated the regulatory antioxidant potential of APN on Nrf2 protein expression by Western blotting. As shown in Fig. 2E,F, C2C12 cells exposed to various concentrations of the APN caused a concentration-dependent increase in Nrf2 expression compared with that in the control group. Furthermore, expression of hemeoxygenase-1 (HO-1), which is downstream molecules of Nrf2, also increased following APN treatment in a concentration-dependent manner (Fig. 2E,G). These data indicate that activating the Nrf2/HO-1 pathway is closely associated with the APN cytoprotective mechanism in C2C12 cells.
APN restores the mitochondrial membrane potential inhibited by H2O2
As previously reported, mitochondria represent both a major source of ROS and the primary target of ROS damage. Excess ROS generated by mitochondria lead to mitochondrial permeability transition pores opening, which causes depolarization of mitochondrial membrane potential8. We next investigated the effects of APN on the mitochondrial membrane potential (ΔΨm). The mitochondrial membrane potential was quantified by tetramethylrhodamine ethyl ester (TMRE), a cationic fluorescent stain that accumulates inside the mitochondrial matrix depending on the membrane potential. Mitochondrial morphology was observed by MitoTracker Green FM, a mitochondrial dye that fluoresces independently of the mitochondrial membrane potential. H2O2 treatment resulted in a significant reduction in the membrane potential in C2C12 cells (Fig. 3A,B). However, APN pretreatment caused a marked increase in the membrane potential in H2O2-treated cells (Fig. 3A). APN has the same effect on TMRE fluorescence reduction as assessed by FACS analysis (Fig. S1). Bongkrekic acid (BA) is an inhibitor of adenine nucleotide translocase, which is a component of the MPTP complex. Therefore, BA prevents mitochondrial depolarization. Interestingly, similar to the result obtained with APN, BA pretreatment increased cell viability in response to H2O2 treatment (Fig. 3C). Thus, APN may act as an inhibitor of MPTP to prevent mitochondrial depolarization.
APN partially blocks the colocalization of mitochondria with autophagosomes/lysosomes
To assess dynamic autophagy regulation after mitochondrial depolarization, C2C12 cells were transfected with an adenovirus expressing mRFP-GFP-LC3. In the transfected cells, autophagosomes are labeled green and red (merged in yellow), and autolysosomes are only labeled red because GFP signals are rapidly quenched under conditions of low lysosomal pH. As shown in Fig. 4A,B, we observed a markedly increased number of autophagosomes and autolysosomes after H2O2 treatment, whereas autolysosomes puncta accumulation was decreased in C2C12 cells upon APN pretreatment. To assess the potential colocalization between mitochondria and autophagosomes, C2C12 cells were transfected with GFP-LC3, followed by staining with MitoTracker Red (TOMM20) for mitochondria. Colocalization between mitochondria and of LC3-labelled autophagosomes was present in C2C12 cells after H2O2 treatment, whereas APN markedly decreased the colocalization (Fig. 4C,D). Damaged mitochondria are wrapped into autophagosomes and delivered to lysosomes for degradation; thus, we assessed the colocalization of lysosomes and mitochondria after mitochondrial depolarization. Lysosomes and mitochondria were labeled with LysoTracker Red and MitoTracker Green FM, respectively. Similarly, APN decreased the colocalization of mitochondria with lysosomes in response to H2O2 treatment (Fig. 4E,F).
APN suppresses H2O2-induced mitophagy
Mitophagy can be observed biochemically by measuring the degradation of mitochondrial proteins from the inner membrane. Here, we used the mitochondrial protein TIM23 as an indicator of mitophagy40, 41. We evaluated the time course of TIM23, LC3 and p62 protein levels in response to H2O2 treatment. According to the TIM23 levels, we found a dramatic decrease in mitophagy after H2O2 treatment (5 mmol/L) in C2C12 cells. H2O2 administration did not induce significant changes in p62 expression from 0.5 to 1 h; however, the level of LC3 increased over time (Fig. 5A,B). Immunoblotting revealed that pretreatment with various concentrations APN suppressed H2O2-induced degradation of TIM23 without affecting the LC3-I to LC3-II transition (Fig. 5C). Numerous studies have analyzed specific regulators of mitophagy including Pink1/Parkin in mammalian systems42–44. In response to depolarization of the mitochondria due in part to ROS generation, Pink1 is stabilized on the outer mitochondrial membrane and selectively recruits Parkin to damaged mitochondria45, 46. Following its recruitment to the damaged mitochondria, Parkin promotes the degradation of diverse mitochondrial membrane via its E3 ubiquitin ligase activity44, 47. We evaluated time course of Pink1 and Parkin protein levels in response to H2O2 treatment. H2O2 administration (5 mM) induced significant increases in Pink1 and Parkin expression over time, which were in accordance with the increase observed in LC3 expression (Fig. 5A). Pretreatment with various concentrations APN suppressed increases of Pink1 and Parkin (Fig. 5C). To demonstrate that mitochondria were degraded by an autophagic process, we treated C2C12 cells with the lysosomotropic inhibitor chloroquine diphosphate (CQ) to prevent autophagosome-lysosome fusion. CQ markedly reversed the H2O2-induced loss of TIM23 in control cells without significantly affecting TIM23 levels in APN-treated cells. These results suggest that APN inhibits H2O2-induced mitochondrial degradation by autophagy (Fig. 5D,E). To analyze changes in the number of mitochondria as a consequence of mitophagy induced by H2O2 treatment, we examined alterations in the mitochondrial DNA copy number by real-time PCR. As observed in Fig. 5F, H2O2-induced loss of mtDNA was significantly prevented by APN.
APN inhibits H2O2-induced apoptosis
Accumulating evidence has demonstrated that APN prevents oxidative stress-induced apoptosis. Therefore, we sought to determine the molecular mechanism of APN in cell death induced by H2O2. Higher Bax and lower Bcl-2 levels were detected in H2O2-induced cells compared with controls (Fig. 6A,B); however, no significant changes in P53 expression were found (Fig. 6C). We performed quantitative RT-PCR to examine the mRNA levels of Bax. Interestingly, APN pretreatment significantly reduced the transcript levels of Bax in H2O2-induced cells compared with controls (Fig. 6D). Immunoblotting analysis revealed that various concentrations of APN resulted in potent downregulation of Bax/Bcl-2 protein expression, which also determined the apoptotic potential in C2C12 cells (Fig. 6E,F).
Discussion
ROS can oxidize cellular components and thus pose a threat to cell integrity. Several defense mechanisms have been demonstrated to protect cells against oxidative stress; such mechanisms include removal of specific proteins by the ubiquitin–proteasome system, upregulation of antioxidants and elimination of damaged organelles by autophagy4. These defense systems are compromised in conditions of excess ROS, which ultimately leads to cell death through various overlapping signaling pathways and cascades3. In this study, we investigated whether APN exerted protective effects against oxidative stress-induced cytotoxicity. Our results indicated that APN significantly attenuated H2O2-induced cytotoxicity in C2C12 cells, supporting that APN exerted antioxidant properties. Moreover, APN upregulated Nrf2 and HO-1 protein expression in a concentration-dependent manner. Therefore, we presumed that APN might activate the Nrf2/HO-1 pathway to eliminate the enhanced ROS generation induced by H2O2, thereby reducing H2O2-induced apoptosis.
Autophagy has an essential role in differentiation and development and has been associated with myopathies, neurodegenerative diseases, pathogen infections and cancer4. When survival programs fail, death mechanisms are activated in response to oxidative stress. In addition to its role in cell survival, autophagy has recently been reported to induce cell death48, which is referred to as type II cell death49–51. In Parkinson’s disease, for example, oxidation of dopamine leads to oxidative stress, autophagy and cell death. Therefore, autophagy has a dual role in the response to oxidative stress. In our study, excessive ROS induced autophagy and cell death. Moreover, depolarized mitochondria, which are unable to reestablish membrane potential, are excluded and targeted for mitophagy. As recently reported, it is possible that both ROS and depolarization are necessary for the induction of mitophagy22.
In this study, we used mouse-derived C2C12 myoblasts as an in vitro model to determine the role of APN in mitophagy and apoptosis. Adiponectin normally circulates abundantly in the concentration range of 5 to 30 μg/mL. The dose of APN used can be considered in a physiological level. Interestingly, we showed that APN pretreatment suppressed H2O2-induced mitophagy by inhibiting the degradation of mitochondrial TIM23 protein in addition to decreasing global autophagy. Although p62, which exhibited no significant changes in our study, is widely used as a biochemical marker for general autophagy, it is not a reliable marker for H2O2-induced autophagy in C2C12 cells. We found that Pink1 expression increased concomitant with Parkin induction under H2O2 treatment. Expression of lipidated form of LC3 was also elevated, suggesting that Parkin mediated mitochondrial degradation is performed, in part, by mitophagy, although proteasome could be also implicated due to the E3 ubiquitin ligase activity of Parkin. Besides, APN administration to H2O2-treated cells suppressed increases of Pink1 and Parkin. These findings suggest that APN inhibits Parkin E3 ubiquitin ligase and partially blocks the colocalization of mitochondria and autophagosomes/lysosomes. We further demonstrated that APN inhibited C2C12 cell apoptosis by reducing the transcript and protein levels of Bax. However, these results differ from those reported for high-fat diet-induced oxidative stress mouse models, in which APN administration stimulates autophagy and reduces oxidative stress to enhance insulin sensitivity52. Similar to our results, APN ameliorates H2O2-induced autophagy in cardiomyocytes, moreover, loss of APN enhances autophagy in response to Ang-II infusion in vivo 30. Therefore, APN modulation of mitophagy seems to be context and cell-type dependent, which is similar to its effects on other signaling pathways53.
In summary, the results of the present study indicated that APN inhibited oxidative stress-induced cellular damage in C2C12 cells. This beneficial effect was closely associated with its potential to eliminate excess ROS accumulation, to prevent mitochondrial depolarization, to modulate autophagy and to suppress apoptosis (Fig. 7). In other experiment, APN protects against acetaminophen-induced oxidative stress, mitochondrial dysfunction and acute liver injury by promoting autophagy in mice54. Although further studies are necessary to better understand the molecular mechanisms that are involved, our experiments confirm the antioxidant potential of APN and underscore its protective role in skeletal muscle diseases related to oxidative stress.
The reciprocal interactions between autophagy and oxidative stress should also be further investigated, for example, using APN-deficient animal models or autophagy-deficient animal models. Moreover, further studies in rodent models, large humanoid animals and clinical investigations are warranted to validate these findings in vitro models. However, other cellular events, such as ROS, precede changes in mitophagy and autophagy itself may still be viewed as a doubled-edged sword and the temporal nature of the process can lead to distinct cellular consequences.
Methods
Cell culture and reagents
C2C12 myoblasts obtained from the Cell Resource Center (Peking Union Medical College) were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (HyClone, GE) and 100 μg/mL penicillin/streptomycin antibiotics in an incubator with 5% CO2 at 37 °C. Recombinant mouse full-length APN was synthesized by Gencreate (Wuhan, China) and dissolved in phosphate-buffered saline (PBS) at a concentration of 500 μg/mL. Hydrogen peroxide (H2O2) was purchased from Solarbio (Beijing, China). Bongkrekic acid (BA) was purchased from Sigma. Chloroquine diphosphate (CQ) was purchased from InvivoGen.
Cell viability assay
Cells were seeded in 96-well culture plates (4 × 104 cells per well) and incubated for 24 h. The cells were treated with the indicated concentrations of APN in the presence or absence of H2O2 for the indicated times. The effect of APN on the inhibition of cell growth was measured as the percentage of cell viability, which was assessed using a Cell Counting Kit-8 (Dojindo, Kumamoto, Japan) as follows. Ten microliters of Cell Counting Kit-8 solution was added to the medium, and cells were incubated for 1 h in a humidified 5% CO2 atmosphere; the amount of orange formazan staining was calculated by measuring the absorbance at 450 nm using a microplate reader.
ROS measurement
C2C12 myoblasts were plated in 12-well plates at a density of 2 × 105 cells per well and treated with or without 30 μg/mL APN for 24 h. After treatment, the cells were incubated with 10 μM 2′,7′-dichlorofluorescein diacetate (DCFH-DA, Beyotime, S0033) for 30 min at 37 °C in the dark and then incubated with or without 5 mM H2O2 for 30 min. The cells were immediately analyzed using an Accuri C6 (BD, CA, USA). A total of 10,000 cells per sample were acquired and analyzed using FlowJo software (Tree star, Ashland, OR).
Annexin V–propidium iodide assay
Apoptosis was assessed using an Annexin V-FITC Apoptosis Analysis Kit (Tianjin Sungene Biotech Co., Ltd.). C2C12 myoblasts were seeded in a 12-well plate at a density of 2 × 105 cells per well and treated with or without 30 μg/mL APN for 24 h. Then, the cells were treated in the presence or absence of 5 mM H2O2 for 30 min. The cell pellets were resuspended in 100 μL buffer with 5 μL annexin V-FITC for 10 min and then incubated with 5 μL propidium iodide for 5 min at room temperature in the dark. A total of 500 μL buffer was added, and the cells were immediately analyzed using an Accuri C6 (BD, CA, USA). A total of 10,000 cells per sample were acquired, and percentage of cell death was analyzed.
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential was measured using the fluorescent strain TMRE (Sigma, 87917). C2C12 myoblasts treated with or without APN were treated with or without 5 mM H2O2 for 30 min and then incubated with TMRE (50 nM) and MitoTracker Green FM (200 nM) (Beyotime, C1048) for 30 min at 37 °C. The relative fluorescence intensity of TMRE was quantified using Image-Pro Plus 6 Windows Software (Media Cybernetics, USA). Or C2C12 myoblasts treated with or without APN were treated with or without 5 mM H2O2 for 30 min and then incubated with TMRE (50 nM) for 30 min at 37 °C. A total of 200 μL PBS/0.2% BSA was added, and the cells were immediately analyzed using an Accuri C6 (BD, CA, USA). A total of 10,000 cells per sample were acquired and analyzed using FlowJo software (Tree star, Ashland, OR). The data shown are representative of three independent experiments.
Analysis of autophagic flux
C2C12 myoblasts stably transfected with Ad-mRFP-GFP-LC3 (Hanbio, Shanghai, China) were seeded on glass cover slips. Twenty-four hours after transfection, the cells were treated with or without APN (30 mg/mL up to 24 h). The cells were then stimulated with H2O2 for 30 min to induce autophagy. Coverslips were washed twice with PBS 1X and mounted on glass slides with fluorescent mounting medium Fluoroshield™ with DAPI (eBioscience) and visualized in an Olympus FV1000 confocal microscope.
Immunofluorescence and laser confocal imaging
C2C12 myoblasts stably transfected with Ad-GFP-LC3 (Hanbio, Shanghai, China) were seeded on glass cover slips. Twenty-four hours after transfection, the cells were treated with or without APN (30 μg/mL up to 24 h). The cells were then stimulated with H2O2 for 30 min. After that, cells were fixed for 15 minutes with 4% paraformaldehyde and washed twice with PBS 1X. Cells were blocked and permeabilized with PBS 1X + 0.2% Triton X-100 for 15 minutes at room temperature. After washing twice with PBS 1X, cells were incubated with a rabbit monoclonal TOMM20 antibody (Abcam) diluted 1:250 in 5% BSA O/N at 4 °C and washed twice with PBS 1X followed by incubation with a secondary anti-rabbit IgG antibody, conjugated to Alexa 555 (1:200) for 1 hour at room temperature. Coverslips were washed twice with PBS 1X and mounted on glass slides with fluorescent mounting medium Fluoroshield™ with DAPI (eBioscience) and visualized in an Olympus FV1000 confocal microscope.
To determine colocalization between mitochondria and lysosomes, C2C12 myoblasts were loaded with 200 nM MitoTracker Green FM (Beyotime, C1048) and 50 nM LysoTracker Red (Beyotime, C1046) for 30 min at 37 °C. Cell images were obtained using an Olympus FV1000 confocal microscope. The colocalization of mitochondria and lysosomes was analyzed according to the number of mitochondria-localized lysosomes.
qRT-PCR gene expression analysis
Total RNA was isolated with TRIzol reagent (Invitrogen, Carlsbad, USA) according to the manufacturer’s instructions. Relative gene expression was detected using quantitative RT-PCR. Total RNA was reverse-transcribed using a reverse transcription kit (Takara, Japan). Quantitative PCRs were performed using SYBR Green PCR Master Mix (Takara, Japan) according to the manufacturer’s instructions. Relative mRNA levels were normalized to Gapdh expression. The primer sequences of the mouse gene are as follows:
Bax forward primer, TGAAGACAGGGGCCTTTTTG;
Bax reverse primer, AATTCGCCGGAGACACTCG (GenBank # NC_000073.6).
Gapdh forward primer, CCATGTTCGTCATGGGTGTGAACCA;
Gapdh reverse primer, GCCAGTAGAGGCAGGGATGATGTTC (GenBank # NC_000072.6).
Western blot analysis
Western blot analysis was conducted to detect the expression of TIM23, LC3, p62, Bax, Bcl-2, P53, Nrf2, HO-1, Pink1, Parkin and β-actin protein in C2C12 myoblasts. LC3 rabbit monoclonal antibody and p62 rabbit polyclonal antibody (1:1000 dilution) were purchased from Cell Signaling (Beverly, MA, USA). Bax, Bcl-2, Nrf2, HO-1 and Parkin rabbit monoclonal antibodies (1:1000) were purchased from Abcam. Pink1 rabbit polyclonal antibody (1:1000) was purchased from ABclonal Technology. TIM23 and P53 rabbit polyclonal antibodies (1:1000) were purchased from Proteintech. β-actin mouse monoclonal antibody (1:2000) was purchased from Sungene. RIPA lysis buffer with 1% phosphatase inhibitor cocktail and 1 mM PMSF was used for the whole-cell lysates. Protein concentrations were detected via the BCA method (Biomed, Beijing, China) according to the manufacturer’s instructions. Equal amounts of protein were separated via 12% SDS-PAGE, transferred to PVDF membranes, and subsequently detected using various primary antibodies. The membranes were incubated for 1.5 h at room temperature with the appropriate secondary HRP-conjugated antibody (1:5000; Tianjin Sungene Biotech) and visualized using an ECL detection kit (Millipore Corporation, Billerica, MA, USA). The densities of specific bands were quantified using ImageJ software.
Mitochondrial DNA content
Genomic DNA was isolated with TIANamp Genomic DNA Kit (TIANGEN BIOTECH (BEIJING) CO., LTD) according to the manufacturer’s instructions. Quantitative PCRs were performed using SYBR Green PCR Master Mix (Takara, Japan) according to the manufacturer’s instructions40. To quantify the amount of mtDNA present per nuclear genome, we used the following primers55:
mtDNA forward primer, CCTATCACCCTTGCCATCAT;
mtDNA reverse primer, GAGGCTGTTGCTTGTGTGAC (GenBank # NC_000085.6).
To quantify nuclear DNA, we used a primer set that detects the Pecam gene:
nuclear DNA forward primer, ATGGAAAGCCTGCCATCATG;
nuclear DNA reverse primer, TCCTTGTTGTTCAGCATCAC (GenBank # NC_000077.6).
Statistical analysis
The data are presented as the mean values ± SEM of at least three independently repeated experiments. One-way ANOVA followed by Tukey’s HSD post hoc test was used to measure differences between mean values of the different treated groups. p < 0.05 was considered significant. The values were analyzed using GraphPad Prism, version 6.0 (GraphPad Software, San Diego, CA, USA).
Electronic supplementary material
Acknowledgements
This work is supported by the National Natural Science Foundation of China through Grant 81172864, 81272317, 31402097, 81302568 and 81301026; Chinese Postdoctoral Science Foundation through Grant 2014M561191; China Spark Program through Grant 2015GA610005.
Author Contributions
Y.L. and R.Z. conception and design of research; Y.R., Y.L., J.Y., M.M., D.Z. and Z.X. performed experiments; Y.R. and Y.L. analyzed data; Z.Z., H.L., H.Y., L.J., L.Z., Q.Z. and S.M. interpreted results of experiments; Y.R. and Y.L. prepared figures; Y.R., and Y.L. drafted manuscript; Y.D.,S.M. and R.Z. edited and revised manuscript; R.Z. approved final version of manuscript.
Competing Interests
The authors declare that they have no competing interests.
Footnotes
Yinghui Ren, Yan Li and Jun Yan contributed equally to this work.
Electronic supplementary material
Supplementary information accompanies this paper at doi:10.1038/s41598-017-03319-2
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Shuqin Mu, Email: mushq@163.com.
Rongxin Zhang, Email: rongxinz@yahoo.com.
Yurong Da, Email: dayr@tmu.edu.cn.
References
- 1.Kang JS, et al. The Cytoprotective Effect of Petalonia binghamiae Methanol Extract against Oxidative Stress in C2C12 Myoblasts: Mediation by Upregulation of Heme Oxygenase-1 and Nuclear Factor-Erythroid 2 Related Factor 2. Marine drugs. 2015;13:2666–2679. doi: 10.3390/md13052666. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.D’Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nature reviews. Molecular cell biology. 2007;8:813–824. doi: 10.1038/nrm2256. [DOI] [PubMed] [Google Scholar]
- 3.Kang JS, et al. Nrf2-mediated HO-1 induction contributes to antioxidant capacity of a Schisandrae Fructus ethanol extract in C2C12 myoblasts. Nutrients. 2014;6:5667–5678. doi: 10.3390/nu6125667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends in cell biology. 2007;17:422–427. doi: 10.1016/j.tcb.2007.07.009. [DOI] [PubMed] [Google Scholar]
- 5.Noubade R, et al. NRROS negatively regulates reactive oxygen species during host defence and autoimmunity. Nature. 2014;509:235–239. doi: 10.1038/nature13152. [DOI] [PubMed] [Google Scholar]
- 6.Kasahara A, Scorrano L. Mitochondria: from cell death executioners to regulators of cell differentiation. Trends in cell biology. 2014;24:761–770. doi: 10.1016/j.tcb.2014.08.005. [DOI] [PubMed] [Google Scholar]
- 7.Pohjoismaki JL, et al. Oxidative stress during mitochondrial biogenesis compromises mtDNA integrity in growing hearts and induces a global DNA repair response. Nucleic acids research. 2012;40:6595–6607. doi: 10.1093/nar/gks301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gong S, et al. A deafness-associated tRNAHis mutation alters the mitochondrial function, ROS production and membrane potential. Nucleic acids research. 2014;42:8039–8048. doi: 10.1093/nar/gku466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Penna C, Perrelli MG, Pagliaro P. Mitochondrial pathways, permeability transition pore, and redox signaling in cardioprotection: therapeutic implications. Antioxidants & redox signaling. 2013;18:556–599. doi: 10.1089/ars.2011.4459. [DOI] [PubMed] [Google Scholar]
- 10.Fischer F, Hamann A, Osiewacz HD. Mitochondrial quality control: an integrated network of pathways. Trends in biochemical sciences. 2012;37:284–292. doi: 10.1016/j.tibs.2012.02.004. [DOI] [PubMed] [Google Scholar]
- 11.Scheibye-Knudsen M, Fang EF, Croteau DL, Wilson DM, 3rd, Bohr VA. Protecting the mitochondrial powerhouse. Trends in cell biology. 2015;25:158–170. doi: 10.1016/j.tcb.2014.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Rugarli EI, Langer T. Mitochondrial quality control: a matter of life and death for neurons. The EMBO journal. 2012;31:1336–1349. doi: 10.1038/emboj.2012.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Springer MZ, Macleod KF. In Brief: Mitophagy: mechanisms and role in human disease. The Journal of pathology. 2016;240:253–255. doi: 10.1002/path.4774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nature reviews. Molecular cell biology. 2009;10:458–467. doi: 10.1038/nrm2708. [DOI] [PubMed] [Google Scholar]
- 15.Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nature cell biology. 2010;12:814–822. doi: 10.1038/ncb0910-814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Youle RJ, Narendra DP. Mechanisms of mitophagy. Nature reviews. Molecular cell biology. 2011;12:9–14. doi: 10.1038/nrm3028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Farre JC, Subramani S. Peroxisome turnover by micropexophagy: an autophagy-related process. Trends in cell biology. 2004;14:515–523. doi: 10.1016/j.tcb.2004.07.014. [DOI] [PubMed] [Google Scholar]
- 18.Bernales S, McDonald KL, Walter P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS biology. 2006;4:e423. doi: 10.1371/journal.pbio.0040423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hamasaki M, Noda T, Baba M, Ohsumi Y. Starvation triggers the delivery of the endoplasmic reticulum to the vacuole via autophagy in yeast. Traffic. 2005;6:56–65. doi: 10.1111/j.1600-0854.2004.00245.x. [DOI] [PubMed] [Google Scholar]
- 20.Kruse KB, Brodsky JL, McCracken AA. Characterization of an ERAD gene as VPS30/ATG6 reveals two alternative and functionally distinct protein quality control pathways: one for soluble Z variant of human alpha-1 proteinase inhibitor (A1PiZ) and another for aggregates of A1PiZ. Molecular biology of the cell. 2006;17:203–212. doi: 10.1091/mbc.E04-09-0779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Yorimitsu T, Klionsky DJ. Eating the endoplasmic reticulum: quality control by autophagy. Trends in cell biology. 2007;17:279–285. doi: 10.1016/j.tcb.2007.04.005. [DOI] [PubMed] [Google Scholar]
- 22.Prieto-Dominguez N, et al. Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy. Journal of pineal research. 2016;61:396–407. doi: 10.1111/jpi.12358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Xu Y. Autophagy Contributes to Caspase-independent Macrophage Cell Death. Journal of Biological Chemistry. 2006;281:19179–19187. doi: 10.1074/jbc.M513377200. [DOI] [PubMed] [Google Scholar]
- 24.Jortay J, et al. Local induction of adiponectin reduces lipopolysaccharide-triggered skeletal muscle damage. Endocrinology. 2010;151:4840–4851. doi: 10.1210/en.2009-1462. [DOI] [PubMed] [Google Scholar]
- 25.Iwabu M, et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature. 2010;464:1313–1319. doi: 10.1038/nature08991. [DOI] [PubMed] [Google Scholar]
- 26.Wang X, et al. Adiponectin abates atherosclerosis by reducing oxidative stress. Medical science monitor: international medical journal of experimental and clinical research. 2014;20:1792–1800. doi: 10.12659/MSM.892299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Zhang, K. et al. Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARgamma/RORgammat Pathway. Molecular neurobiology, doi:10.1007/s12035-016-0036-7 (2016). [DOI] [PubMed]
- 28.Wang H, et al. Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury. Scientific reports. 2016;6:19445. doi: 10.1038/srep19445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Jortay J, et al. Adiponectin and skeletal muscle: pathophysiological implications in metabolic stress. The American journal of pathology. 2012;181:245–256. doi: 10.1016/j.ajpath.2012.03.035. [DOI] [PubMed] [Google Scholar]
- 30.Essick EE, et al. Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes. PloS one. 2013;8:e68697. doi: 10.1371/journal.pone.0068697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Fulle S, et al. The contribution of reactive oxygen species to sarcopenia and muscle ageing. Experimental Gerontology. 2004;39:17. doi: 10.1016/j.exger.2003.09.012. [DOI] [PubMed] [Google Scholar]
- 32.Meng SJ, Yu LJ. Oxidative Stress, Molecular Inflammation and Sarcopenia. International Journal of Molecular Sciences. 2010;11:1509–1526. doi: 10.3390/ijms11041509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Baumann, C. W., Kwak, D., Liu, H. & Thompson, L. V. Age-induced oxidative stress: How does it influence skeletal muscle quantity and quality? Journal of Applied Physiology121, jap.00321.02016 (2016). [DOI] [PMC free article] [PubMed]
- 34.Moulin, M. & Ferreiro, A. Muscle redox disturbances and oxidative stress as pathomechanisms and therapeutic targets in early-onset myopathies. Seminars in cell & developmental biology, doi:10.1016/j.semcdb.2016.08.003 (2016). [DOI] [PubMed]
- 35.Terrill JR, et al. Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies. The FEBS journal. 2013;280:4149–4164. doi: 10.1111/febs.12142. [DOI] [PubMed] [Google Scholar]
- 36.Pal R, et al. Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy. Nature communications. 2014;5:4425. doi: 10.1038/ncomms5425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kang JS, et al. Sargassum horneri methanol extract rescues C2C12 murine skeletal muscle cells from oxidative stress-induced cytotoxicity through Nrf2-mediated upregulation of heme oxygenase-1. BMC complementary and alternative medicine. 2015;15:17. doi: 10.1186/s12906-015-0538-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Chapple SJ, Siow RC, Mann GE. Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. International Journal of Biochemistry & Cell Biology. 2012;44:1315–1320. doi: 10.1016/j.biocel.2012.04.021. [DOI] [PubMed] [Google Scholar]
- 39.Jeong WS, Jun M, Kong AN. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxidants & redox signaling. 2006;8:99–106. doi: 10.1089/ars.2006.8.99. [DOI] [PubMed] [Google Scholar]
- 40.Min C, et al. MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis. Oncotarget. 2016;7:42274–42287. doi: 10.18632/oncotarget.9786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Li J, et al. Mitochondrial outer-membrane E3 ligase MUL1 ubiquitinates ULK1 and regulates selenite-induced mitophagy. Autophagy. 2015;11:1216–1229. doi: 10.1080/15548627.2015.1017180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Ashrafi G, Schwarz TL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death & Differentiation. 2012;20:31–42. doi: 10.1038/cdd.2012.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Durcan TM, Fon EA. The three ‘P’s of mitophagy: PARKIN, PINK1, and post-translational modifications. Genes & Development. 2015;29:989–999. doi: 10.1101/gad.262758.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. Journal of Cell Biology. 2008;183:795–803. doi: 10.1083/jcb.200809125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Matsuda N, et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. Journal of Cell Biology. 2010;189:211. doi: 10.1083/jcb.200910140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Narendra DP, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS biology. 2010;8:e1000298. doi: 10.1371/journal.pbio.1000298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Sarraf SA, et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013;496:372–376. doi: 10.1038/nature12043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Li, S. et al. MiR-17 regulates autophagy to promote hepatic ischemia-reperfusion injury via suppression of Stat3 expression. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, doi:10.1002/lt.24606 (2016). [DOI] [PubMed]
- 49.Codogno P, Meijer A. J. Autophagy and signaling: their role in cell survival and cell death. Cell death and differentiation. 2005;12(Suppl 2):1509–1518. doi: 10.1038/sj.cdd.4401751. [DOI] [PubMed] [Google Scholar]
- 50.Gozuacik, D. & Kimchi, A. Autophagy and Cell Death. 78, 217-245, doi:10.1016/s0070-2153(06)78006-1 (2007). [DOI] [PubMed]
- 51.Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science. 2004;306:990–995. doi: 10.1126/science.1099993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Xu A, Sweeney G. Emerging role of autophagy in mediating widespread actions of ADIPOQ/adiponectin. Autophagy. 2015;11:723–724. doi: 10.1080/15548627.2015.1034418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Katira A, Tan PH. Evolving role of adiponectin in cancer-controversies and update. Cancer biology & medicine. 2016;13:101–119. doi: 10.20892/j.issn.2095-3941.2015.0092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Lin Z, et al. Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice. Journal of hepatology. 2014;61:825–831. doi: 10.1016/j.jhep.2014.05.033. [DOI] [PubMed] [Google Scholar]
- 55.Chen H, et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell. 2010;141:280–289. doi: 10.1016/j.cell.2010.02.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.